Drug Profile
AZD 1480
Alternative Names: AZD1480Latest Information Update: 22 Sep 2015
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Amines; Antineoplastics; Pyrazoles; Pyrimidines; Small molecules
- Mechanism of Action Janus kinase 1 inhibitors; Janus kinase-2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Liver cancer; Myeloproliferative disorders; Solid tumours
Most Recent Events
- 31 Dec 2012 Discontinued - Phase-I for Solid tumours in South Korea (PO)
- 31 Oct 2012 Discontinued - Phase-I for Solid tumours in USA (PO)
- 31 Jan 2012 Discontinued - Phase-I for Liver cancer in South Korea (PO)